scholarly journals Global Health Partnerships During the COVID-19 Pandemic: Perspectives and Insights from International Partners

2021 ◽  
Author(s):  
Megan S. McHenry ◽  
Reena P. Tam ◽  
Amira A. Nafiseh ◽  
Mary Ann Etling ◽  
Adelaide E. Barnes ◽  
...  
Keyword(s):  
United States ◽  
Decision Making ◽  
Global Health ◽  
The United States ◽  
Structured Interviews ◽  
Cross Sectional ◽  
Health Partnerships ◽  
The Future ◽  
Positive Experiences ◽  
E Mail

Global health partnerships (GHPs) have encountered many challenges during the coronavirus disease 2019 (COVID-19) pandemic. New perspectives and insights are needed to guide GHPs when navigating current and future collaborations. This study aimed to understand perspectives and insights of international partners regarding how the COVID-19 pandemic impacted their GHPs with institutions in the United States. We performed a cross-sectional qualitative study conducted through virtual semi-structured interviews performed between June 12, 2020 and July 22, 2020. We queried academic institutions based in the United States to refer individuals from their corresponding international GHP organizations. We invited these individuals to participate in virtual interviews that were audio-recorded and transcribed. We analyzed data qualitatively to identify themes. Eighty-four United States partners provided e-mail addresses for international partners. Ten individuals from these GHPs completed the interview. Participants reported overall positive experiences with their United States-based partners during the pandemic. The following themes emerged: imbalanced decision-making; worry about partnership continuity; opportunity to optimize communication within partnerships; interest in incorporating technology to facilitate engagement; and a desire for increased bilateral exchanges. Several challenges appeared to exist before COVID-19 and were highlighted by the pandemic. Most respondents were optimistic regarding the future of their GHPs. However, concerns were expressed regarding the implications of fewer in-person international experiences with United States trainees and the desire for stronger communication. Although our results do not represent the perspectives and insights of all GHPs, they provide considerations for the future. We urge institutions in the United States to re-examine and strive for equitable relationships with their international partners.

“Why can’t I Have the Office Jobs?”: Immigrant Latinx Transgender Peoples’ Experiences with Seeking Employment

2021 ◽  
pp. 089484532110629
Author(s):  
Roberto L. Abreu ◽  
Kirsten A. Gonzalez ◽  
Louis Lindley ◽  
Cristalís Capielo Rosario ◽  
Gabriel M. Lockett ◽  
...  
Keyword(s):  
United States ◽  
Thematic Analysis ◽  
Community Sample ◽  
The United States ◽  
Disability Benefits ◽  
Structured Interviews ◽  
Future Directions ◽  
Transgender People ◽  
Job Opportunities ◽  
Positive Experiences

Research has documented the experiences of transgender people in seeking employment. To date, no scholarship has explored the experiences of immigrant Latinx transgender people seeking employment in the United States. Using an intersectionality framework, the present study aimed to uncover the experiences of immigrant Latinx transgender people as they sought employment in the United States. A community sample of 18 immigrant Latinx transgender people from a large metropolitan city in Florida engaged in semi-structured interviews. Thematic analysis revealed five themes related to participants’ experiences seeking employment, including: (1) discrimination, (2) limited options, (3) positive experiences, (4) momentary de-transition, and (5) disability benefits as financial relief. Future directions such as exploring ways in which immigrant Latinx transgender people resist discrimination while seeking job opportunities are discussed. Implications for practice and advocacy such as advocating for equitable employment policies that acknowledge the intersectional experiences of this community are presented.

scholarly journals An Investigation into the Vaccine for Covid-19 Within the United States

2021 ◽  
Vol 2020 ◽  
Author(s):  
Femi Obasun
Keyword(s):  
United States ◽  
Decision Making ◽  
Incomplete Data ◽  
The United States ◽  
Decision Makers ◽  
Vaccine Candidates ◽  
The Future

This report looks into the administering process of vaccines within the United States and the method designed to aid the decision-makers' process. The study method is based on a quantitative representation in which vaccine candidates are administered.   The procedure utilizes the corresponding (incomplete) data that could theoretically be used in other decision-making methods. The information provided by the vaccine manufacture is somewhat vague. The process entails predicting the future and gaps.  The study interview 1200 vaccinated patients to give an opinion based on the patients.

Multiple Myeloma Mortality Incidence Prevalence of Disease - Mmy Mind Study

Blood ◽  
2020 ◽  
Vol 136 (Supplement 1) ◽  
pp. 10-11
Author(s):  
Humberto Martínez Cordero ◽  
Jessica Zapata Malagon ◽  
Lorena Cubillos Osorio ◽  
Alejandro Rico Mendoza ◽  
Alexandra Porras Ramírez ◽  
...  
Keyword(s):  
United States ◽  
Multiple Myeloma ◽  
Direct Method ◽  
The United States ◽  
International Agency ◽  
Sources Of Information ◽  
Andean Region ◽  
Cross Sectional ◽  
The Future ◽  
Incidence Prevalence

Background Multiple myeloma (MM) is a heterogeneous and incurable disease that evolves from asymptomatic premalignant conditions. The worldwide incidence, prevalence and mortality are well known thanks to data reported by the International Agency for Research on Cancer (IARC) and by the GLOBOCAN World Cancer Observatory. The data provided by Colombia to these reports comes from the population cancer registries corresponding to 5 cities whose most up-to-date data are from 2018. National data can also be found in the base of the high-cost account. Although it is true that there are excellent sources of information, it is believed that there is a significant underreporting of the prevalence of the disease, which makes it necessary to optimize the information to achieve the establishment of programs oriented to work on better control of this type of hematological cancer. The study MiMENTe (Mieloma Múltiple Epidemiología Nacional y territorial) is a collaborative effort to know the reality of the disease in terms of incidence, prevalence and mortality in Colombia as a first step to control the disease even in the premalignant stages for the future wanting to position itself as a model for the control of MM in developing countries. Methods MiMENTE (Mieloma Múltiple, Epidemiología Nacional y territorial) is a multiphase study that is going through its first stage through a cross-sectional study in Colombia. The total population diagnosed with Multiple Myeloma (ICD Code 10 C900) during the 2008-2018 period was included in the RIPS Individual Service Delivery Registry in Colombia and a comparison was made with the available data from GLOBOCAN (Global Cancer Observatory) and High Cost Account. Records that had an unidentified diagnosis were excluded. For this phase, a comparison is made of the data from the registries of the three entities described, three measures of frequency are established: Incidence, prevalence and mortality, standardizing the latter by means of a direct method, making the Colombian population comparable with large countries such as the United States. and Spain cataloged as centers of reference in the management and diagnosis of Multiple Myeloma. Variables such as ethnicity, age, place of origin, health regime, place of death will be studied in the future in later phases of the study. Results Between 2009 and 2018 (10 years), 26,356 MM diagnoses were found throughout the national territory of Colombia. The departments where the most attention to patients with this diagnosis was presented were Cundinamarca, Valle del Cauca, Antioquia, Santander, Bolívar and Atlántico Figure 1. The standardized incidence rate for Colombia in 2018 was 1.79 x 100,000 inhabitants, being higher in the Andean region as shown in the heat map. Graph 1. The total number of prevalent cases per year varied from 1138 cases in 2009 to 4474 cases in 2018 being for this year the adjusted prevalence of 8.97 x 100,000 inhabitants / year Graph 2. When the prevalence is analyzed by regions it is higher in the Andean region Graph 3. During this entire period of time, 5481 deaths were found, being 20.80%. The highest mortality occurred in the departments of Vichada, Meta, Caquetá, Risaralda, Atlántico and the island of San Andrés. Figure 2. The age-standardized mortality rate for Colombia is 1,39x100,000 inhabitants (Adjusted with the population of the United States). The most up-to-date data from IARC and GLOBOCAN are those corresponding to the year 2018. A comparison was made of our data with those reported in this last registry for Colombia in addition to the high-cost account. Comparative data were developed with the population of the United States, standardizing this population and it was also compared with the data reported for Spain. The prevalence of the disease is higher in Colombia than reported by GLOBOCAN, IARC and High cost drug account Table 1. Conclusion This is the first report of the MiMENTe study that shows the incidence, prevalence and mortality of patients with 10-year-old multiple myeloma in Colombia. The prevalence of the disease is higher than that reported by international registries. The regions with the highest incidence were those belonging to the andean region. The highest prevalence was confirmed in Bogotá and Antioquia and the highest mortality was observed in the Orinoco region. Disclosures Idrobo: Takeda: Honoraria, Speakers Bureau; Janssen: Honoraria, Speakers Bureau; Tecnofarma: Honoraria, Speakers Bureau; Amgen: Honoraria, Speakers Bureau; Abbvie: Honoraria, Speakers Bureau.

scholarly journals The Future Role of the United States in Global Health

2017 ◽  
Vol 70 (25) ◽  
pp. 3140-3156 ◽  
Author(s):  
Valentin Fuster ◽  
Jendayi Frazer ◽  
Megan Snair ◽  
Rajesh Vedanthan ◽  
Victor Dzau ◽  
...  
Keyword(s):  
United States ◽  
Global Health ◽  
The United States ◽  
Future Role ◽  
The Future

scholarly journals Prenatal care experiences among pregnant women with obesity in Wisconsin, United States: a qualitative quality improvement assessment

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Danielle J. Hurst ◽  
Nicholas B. Schmuhl ◽  
Corrine I. Voils ◽  
Kathleen M. Antony
Keyword(s):  
United States ◽  
Prenatal Care ◽  
Pregnant Women ◽  
Perinatal Care ◽  
The United States ◽  
Structured Interviews ◽  
Large Size ◽  
Midwest Region ◽  
Positive Experiences

Abstract Background Stigma and bias experienced during prenatal care can affect quality of care and, ultimately, the health of pregnant women with obesity and their infants. We sought to 1) better understand the bias and stigma that women with BMIs ≥40 kg/m2 experience while receiving prenatal care, 2) gauge women’s interest in group prenatal education for women with obesity, and 3) gather feedback about their preferred weight-related terminology. Methods We conducted and thematically content-analyzed 30 semi-structured interviews of women with BMIs ≥40 kg/m2 who received prenatal care at a university-affiliated teaching hospital in the Midwest region of the United States. Results All women recalled positive experiences during their perinatal care during which they felt listened to and respected by providers. However, many also described a fear of weight-related bias or recalled weight-based discrimination. Women reacted favorably to a proposed group prenatal care option for pregnant women with obesity that focused on nutrition, physical activity, and weight management. Women rated “weight” and “BMI” as the most desirable terms for describing weight, while “large size” and “obesity” were rated least desirable. Conclusions Many pregnant women with BMIs ≥40 kg/m2 experience bias in the prenatal care setting. Potential steps to mitigate bias towards weight include improving provider awareness of the experiences and perspectives of this population, expanding prenatal care options targeted towards women with high BMIs, including group care, and using patient-preferred weight-related terminology. Through the remainder of this manuscript, wherever possible, the term “high BMI” will be used in place of the term “obesity” to describe women with BMI ≥ 30 kg/m2 in order to respect the preferred terminology of the women we interviewed.

scholarly journals The Devil You Know? Maybe Not: Four Failures to Demonstrate that Scarcity Magnifies Preference for Familiarity

2019 ◽  
Author(s):  
Stephen Antonoplis ◽  
Serena CHEN
Keyword(s):  
United States ◽  
Decision Making ◽  
Recent Work ◽  
Economic Inequality ◽  
The United States ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Psychological Experience ◽  
The World ◽  
The Devil

As economic inequality increases in the United States and around the world, psychologists have begun to study how the psychological experience of scarcity impacts people's decision making. Recent work in psychology suggests that scarcity—the experience of having insufficient resources to accomplish a goal—makes people more strongly prefer what they already like relative to what they already dislike or like less. That is, scarcity may polarize preferences. One common preference is that for familiarity: the systematic like of more often experienced stimuli, compared to less often experience stimuli. Across four studies—three experiments and one cross-sectional survey (all pre-registered; see https://osf.io/7zyfr/)—we investigated whether scarcity polarizes the preference for familiarity. Despite consistently replicating people's preference for the familiar, we consistently failed to show that scarcity increased the degree to which people preferred the familiar to the unfamiliar. We discuss these results in light of recent failures to replicate famous findings in the scarcity literature.

scholarly journals Donor data vacuuming

2018 ◽  
Vol 5 (2) ◽  
Author(s):  
Sarah Gimbel ◽  
Baltazar Chilundo ◽  
Nora Kenworthy ◽  
Celso Inguane ◽  
David Citrin ◽  
...  
Keyword(s):  
United States ◽  
Sustainable Development ◽  
Data Collection ◽  
Global Health ◽  
Sustainable Development Goals ◽  
The United States ◽  
Health Data ◽  
Poor Countries ◽  
Health Partnerships ◽  
Development Goals

In this essay, we seek to understand how the stunning rise of data vacuuming, necessitated by the pretense of ‘partnership’ within global health, has fundamentally altered how routine health data in poor countries is collected, analyzed, prioritized, and used to inform management and policy. Writing as a team of authors with experiences on multiple sides of global health partnerships in the United States, Mozambique, Nepal, Lesotho, Kenya, and Cote d’Ivoire, we argue that solidarity-based partnership between donor and recipient countries is impossible when evidence production and management is effectively outsourced to external organizations to meet the criteria of donor partners. Specifically, to meet the 2030 Sustainable Development Goals, equity-oriented strategies are critically needed to create data collection, analysis, and use activities that are mutually beneficial and sustainable.

scholarly journals Audio-/Videorecording Clinic Visits for Patient�s Personal Use in the United States: Cross-Sectional Survey (Preprint)

2018 ◽  
Author(s):  
Paul J Barr ◽  
Kyra Bonasia ◽  
Kanak Verma ◽  
Michelle D Dannenberg ◽  
Cameron Yi ◽  
...  
Keyword(s):  
United States ◽  
Health Systems ◽  
The United States ◽  
Clinic Visit ◽  
Cross Sectional ◽  
The Public ◽  
The Us ◽  
The Future ◽  
Personal Use ◽  
Clinic Visits

BACKGROUND Few clinics in the United States routinely offer patients audio or video recordings of their clinic visits. While interest in this practice has increased, to date, there are no data on the prevalence of recording clinic visits in the United States. OBJECTIVE Our objectives were to (1) determine the prevalence of audiorecording clinic visits for patients’ personal use in the United States, (2) assess the attitudes of clinicians and public toward recording, and (3) identify whether policies exist to guide recording practices in 49 of the largest health systems in the United States. METHODS We administered 2 parallel cross-sectional surveys in July 2017 to the internet panels of US-based clinicians (SERMO Panel) and the US public (Qualtrics Panel). To ensure a diverse range of perspectives, we set quotas to capture clinicians from 8 specialties. Quotas were also applied to the public survey based on US census data (gender, race, ethnicity, and language other than English spoken at home) to approximate the US adult population. We contacted 49 of the largest health systems (by clinician number) in the United States by email and telephone to determine the existence, or absence, of policies to guide audiorecordings of clinic visits for patients’ personal use. Multiple logistic regression models were used to determine factors associated with recording. RESULTS In total, 456 clinicians and 524 public respondents completed the surveys. More than one-quarter of clinicians (129/456, 28.3%) reported that they had recorded a clinic visit for patients’ personal use, while 18.7% (98/524) of the public reported doing so, including 2.7% (14/524) who recorded visits without the clinician’s permission. Amongst clinicians who had not recorded a clinic visit, 49.5% (162/327) would be willing to do so in the future, while 66.0% (346/524) of the public would be willing to record in the future. Clinician specialty was associated with prior recording: specifically oncology (odds ratio [OR] 5.1, 95% CI 1.9-14.9; P=.002) and physical rehabilitation (OR 3.9, 95% CI 1.4-11.6; P=.01). Public respondents who were male (OR 2.11, 95% CI 1.26-3.61; P=.005), younger (OR 0.73 for a 10-year increase in age, 95% CI 0.60-0.89; P=.002), or spoke a language other than English at home (OR 1.99; 95% CI 1.09-3.59; P=.02) were more likely to have recorded a clinic visit. None of the large health systems we contacted reported a dedicated policy; however, 2 of the 49 health systems did report an existing policy that would cover the recording of clinic visits for patient use. The perceived benefits of recording included improved patient understanding and recall. Privacy and medicolegal concerns were raised. CONCLUSIONS Policy guidance from health systems and further examination of the impact of recordings—positive or negative—on care delivery, clinician-related outcomes, and patients’ behavioral and health-related outcomes is urgently required.

Sign in / Sign up

Export Citation Format

Share Document